While targeted protein and RNA degradation are hot areas for R&D, the drugs developed so far come with limitations. Now, a new class with broader applications may not be far off. In a study published ...
In a recent study published on the medRxiv* preprint server, researchers conducted blood digital transcriptomics to determine the persistence of severe acute respiratory syndrome coronavirus 2 ...
COVID proved the therapeutic potential of RNA technology – making it more available is the next goal
This work was supported by funding from New Zealand Ministry of Business Innovation and Employment, Research Trust of Victoria University of Wellington and The Hugh Green Foundation. The recent award ...
RNA vaccines against Covid-19 have proven effective at reducing the severity of disease. However, a team of researchers at MIT is working on making them even better. By tweaking the design of the ...
mRNA vaccines can enhance immunotherapy efficacy by activating the immune system, improving outcomes in hard-to-treat tumors. mRNA COVID-19 vaccines enhance immune responses, improving cancer ...
New research reveals that women with long COVID show distinct biological disruptions — including gut inflammation, anemia, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback